Your search returned 13 results.

Sort
Results
1.
Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31271271
Year: 2019
Citation:
  • The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Giovanella L, van Nostrand D
2.
Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 31160436
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
3.
Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30105931
Year: 2018
Citation:
  • Thyroid. 28(9):1083-1093, 2018 Sep.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Van Nostrand D
4.
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 30900516
Year: 2019
Citation:
  • Thyroid. 29(4):461-470, 2019 04.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA
5.
Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature. [Review] MedStar authors:
  • Burman, Kenneth D
  • Heimlich, Layla
  • Kulkarni, Kanchan
  • Van Nostrand, Douglas
  • Veytsman, Irina
PMID:
  • 36792922
Year: 2023
Citation:
  • Thyroid. 33(6):674-681, 2023 06.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Library
  • Medicine/Endocrinology
  • Radiology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Heimlich L, Kulkarni K, Van Nostrand D, Veytsman I
6.
Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors:
  • Van Nostrand, Douglas
PMID:
  • 29650270
Year: 2018
Citation:
  • Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D
7.
Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?. MedStar authors:
  • Burman, Kenneth D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Ylli, Dorina
PMID:
  • 29741712
Year: 2018
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 103(5):1813-1817, 2018 May 01.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Van Nostrand D, Wartofsky L, Ylli D
8.
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. [Review] MedStar authors:
  • Burman, Kenneth D
  • Klubo-Gwiezdzinska, Joanna
  • Mete, Mihriye
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 23186979
Year: 2013
Citation:
  • Endocrine Practice. 19(1):139-48, 2013 Jan-Feb.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L
9.
Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors:
  • Bethancourt, Evelyn
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Orquiza, Michael
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
  • Wu, Di
PMID:
  • 30361377
Year: 2019
Citation:
  • Journal of Nuclear Medicine. 60(5):638-643, 2019 05.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D
10.
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors:
  • Atkins, Francis
  • Burman, Kenneth D
  • Moreau, Shari
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 26357962
Year: 2015
Citation:
  • Thyroid. 25(12):1347-50, 2015 Dec.
Institution:
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Validation Studies
Form of publication:
  • Journal Article
All authors:
  • Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L
11.
Current treatment modalities for spinal metastases secondary to thyroid carcinoma. [Review] MedStar authors:
  • Boyle, Lisa M
  • Burman, Kenneth D
  • Carroll, Nancy M
  • Kushchayeva, Yevgeniya
  • Van Nostrand, Douglas
  • Wexler, Jason
PMID:
  • 24827757
Citation:
  • Thyroid. 24(10):1443-55, 2014 Oct.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Surgery
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Boyle LM, Burman KD, Carroll NM, Kushchayev SV, Kushchayeva YS, Preul MC, Sonntag VK, Teytelboym OM, Van Nostrand D, Wexler JA
12.
Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. MedStar authors:
  • Boyle, Lisa M
  • Burman, Kenneth D
  • Carroll, Nancy M
  • Felger, Erin A
  • Kushchayeva, Yevgeniya
  • Van Nostrand, Douglas
PMID:
  • 24921429
Citation:
  • Thyroid. 24(10):1488-500, 2014 Oct.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
  • Surgery
  • Surgery/Endocrine Surgery
  • Surgery/General Surgery
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bonichon F, Boyle LM, Burman KD, Carroll NM, Felger EA, Kushchayev SV, Kushchayeva YS, Links TP, Preul MC, Sonntag VK, Teytelboym OM, Van Nostrand D
13.
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors:
  • Atkins, Frank B
  • Burman, Kenneth D
  • Chennupati, Shyam P
  • Kharazi, Pejman
  • Khorjekar, Gauri R
  • Mete, Mihriye
  • Moreau, Shari
  • O'Neil, Jeff
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
PMID:
  • 22315442
Year: 2012
Citation:
  • Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L
Pages

Powered by Koha